These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1939648

  • 1. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.
    Herrmann MA, Hay ID, Bartelt DH, Ritland SR, Dahl RJ, Grant CS, Jenkins RB.
    J Clin Invest; 1991 Nov; 88(5):1596-604. PubMed ID: 1939648
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
    Trovato M, Fraggetta F, Villari D, Batolo D, Mackey K, Trimarchi F, Benvenga S.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR, Spruck CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA.
    Cancer Res; 1996 Nov 01; 56(21):5039-43. PubMed ID: 8895761
    [Abstract] [Full Text] [Related]

  • 8. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
    Khosla S, Patel VM, Hay ID, Schaid DJ, Grant CS, van Heerden JA, Thibodeau SN.
    J Clin Invest; 1991 May 01; 87(5):1691-9. PubMed ID: 2022740
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization.
    Singh B, Lim D, Cigudosa JC, Ghossein R, Shaha AR, Poluri A, Wreesmann VB, Tuttle M, Shah JP, Rao PH.
    Surgery; 2000 Dec 01; 128(6):888-93;discussion 893-4. PubMed ID: 11114620
    [Abstract] [Full Text] [Related]

  • 11. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B, Grebe SK, Wang L, Hay ID, Yokomizo A, Liu W, Goellner JR, Grant CS, Smith DI, Eberhardt NL.
    Clin Endocrinol (Oxf); 2000 Jun 01; 52(6):749-57. PubMed ID: 10848880
    [Abstract] [Full Text] [Related]

  • 12. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
    Furlan JC, Bedard YC, Rosen IB.
    Am Surg; 2007 May 01; 73(5):484-91. PubMed ID: 17521005
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L.
    Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH, Lo CY, Chan WF, Lam KY, Wan KY.
    Ann Surg Oncol; 2007 Feb 15; 14(2):730-8. PubMed ID: 17103065
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell.
    Migdalska-Sęk M, Czarnecka KH, Kusiński M, Pastuszak-Lewandoska D, Nawrot E, Kuzdak K, Brzeziańska-Lasota E.
    Mol Diagn Ther; 2019 Jun 15; 23(3):369-382. PubMed ID: 30747408
    [Abstract] [Full Text] [Related]

  • 17. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.
    Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C.
    Cancer Res; 2003 Jun 01; 63(11):2864-71. PubMed ID: 12782592
    [Abstract] [Full Text] [Related]

  • 18. Karyotypic characterization of papillary thyroid carcinomas.
    Roque L, Nunes VM, Ribeiro C, Martins C, Soares J.
    Cancer; 2001 Nov 15; 92(10):2529-38. PubMed ID: 11745186
    [Abstract] [Full Text] [Related]

  • 19. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I, Khodja A, Driouch K, Lidereau R.
    Clin Cancer Res; 1997 Jun 15; 3(6):1009-16. PubMed ID: 9815778
    [Abstract] [Full Text] [Related]

  • 20. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
    Rodrigues-Serpa A, Catarino A, Soares J.
    Cancer Genet Cytogenet; 2003 Feb 15; 141(1):26-31. PubMed ID: 12581895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.